ClinicalTrials.gg
Sign In
Status unknownNCT01804751Updated Aug 25, 2015

Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

An observational study in Preeclampsia, sponsored by West China Second University Hospital. Status unknown. Open to female participants. Per ClinicalTrials.gov, last updated 2015-08-25.

Sponsored by West China Second University Hospital · Observational

The sponsor has not verified this record recently (last verified Jun 2013), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Sex
Female
01

Study summary

The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china

02

Conditions studied

  • Preeclampsia

Browse trials for

03

In context

Pre-Eclampsia

904 studies on the registry are indexed under Pre-Eclampsia; 240 are open to participants now.

Browse Pre-Eclampsia studies →

Lead sponsor

West China Second University Hospital is the lead sponsor of 38 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Chinese women who fulfilled a research definition of preeclampsia, and who were admitted to participating obstetric centres

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • admitted with preeclampsia or had developed preeclampsia after admission

Exclusion criteria

Exclusion Criteria:

  • admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data
05

Study design

Observational model
Cohort
Time perspective
Prospective
Patient registry
No
06

What researchers measure

Primary outcomes

  1. maternal mortality

    Time frame: within 48h of eligibility

Secondary outcomes

  1. serious central nervous system morbidity

    Time frame: within 48h of eligibility

  2. serious cardiorespiratory morbidity

    Time frame: within 48h of eligibility

  3. serious hepatic morbidity.

    Time frame: within 48h of eligibility

  4. serious renal morbidity

    Time frame: within 48h of eligibility

  5. serious haematological morbidity

    Time frame: within 48h of eligibility

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2016 and a primary completion of Dec 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 1, 2013
First posted
Mar 5, 2013
Start
Jan 2016
Primary completionEst.
Dec 2016
Last update
Aug 25, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01804751
Lead sponsor
West China Second University Hospital
Collaborators
Sichuan Academy of Medical Sciences, Guang'an people's hospital of Sichuan province, The First People's Hospital of Neijiang, Suining Central Hospital, Sichuan Provincial Maternal and Child Health Care Hospital, Chengdu Women's and Children's Central Hospital, Luzhou Medical College, pengzhou shi fuyou baojianyuan, Nanchong Central Hospital
Responsible party
Xinghui Liu (professor, West China Second University Hospital) — Principal investigator
First posted
Mar 5, 2013
Start date
Jan 2016
Primary completion
Dec 2016 (estimated)
Last update
Aug 25, 2015

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pre-Eclampsia →

Other studies from this sponsor

West China Second University Hospital

Start the discussion